Summary of Significant Accounting Policies
Significant Accounting Policies [Text Block]
Percentage held by non-affiliates
Sale of Stock Available for Sale, Percentage
Sale of Stock Available for Sale, Percentage
Statistical Measurement [Domain]
Statistical Measurement [Domain]
Award Timing Predetermined
Award Timing Predetermined [Flag]
BOLSTER trial
Bolster Trial [Member]
Bolster Trial
Entity File Number
Entity File Number
Additional Paid-in Capital
Additional Paid-in Capital [Member]
Tabular List, Table
Tabular List [Table Text Block]
License
License [Member]
Gross Unrealized Losses
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax
Trading Arrangements, by Individual
Trading Arrangements, by Individual [Table]
Lisata Therapeutics, Inc. common stockholders- basic (in dollars per share)
Earnings Per Share, Basic
Adjustment to Compensation:
Adjustment to Compensation [Axis]
Named Executive Officers, Footnote
Named Executive Officers, Footnote [Text Block]
Share based compensation expense
Share Based Compensation Expense, General And Administrative Expense
Share Based Compensation Expense, General And Administrative Expense
Total other comprehensive gain
Other Comprehensive Income (Loss), Net of Tax
Schedule of Segment Reporting Information, by Segment
Schedule of Segment Reporting Information, by Segment [Table Text Block]
Option to terminate
Research Collaboration and License Agreement, Option to Terminate
Research Collaboration and License Agreement, Option to Terminate
Schedule of Available-for-Sale Securities Reconciliation
Schedule of Available-for-Sale Securities Reconciliation [Table Text Block]
Adjustment to Compensation, Amount
Adjustment to Compensation Amount
Revenue from collaborative arrangement
Revenue from Collaborative Arrangement, Excluding Revenue from Contract with Customer
Income Tax Holiday [Table]
Income Tax, Holiday [Table]
Other assets
Increase (Decrease) in Other Operating Assets
Vested (in dollars per share)
Weighted Average Exercise Price, Warrants Exercisable
Weighted Average Exercise Price, Warrants Exercisable
Principles of Consolidation
Consolidation, Policy [Policy Text Block]
Share-based compensation
Share-Based Payment Arrangement, Noncash Expense
Investor relations/public relations/communications
Communications and Information Technology
Stock options
Share-Based Payment Arrangement, Option [Member]
Award Timing MNPI Disclosure
Award Timing MNPI Disclosure [Text Block]
Other
Other General and Administrative Expense
Property, Plant and Equipment [Table]
Property, Plant and Equipment [Table]
Long-lived Assets
Property, Plant and Equipment, Impairment [Policy Text Block]
Cash and Cash Equivalents
Cash and Cash Equivalents, Policy [Policy Text Block]
Antidilutive Securities [Axis]
Antidilutive Securities [Axis]
Total Lisata Therapeutics, Inc. stockholders' equity
Equity, Attributable to Parent
Schedule of Available-for-sale Securities [Table]
Debt Securities, Available-for-Sale [Table]
Other comprehensive gain (loss):
Other Comprehensive Income (Loss), Net of Tax [Abstract]
Insider Trading Policies and Procedures [Line Items]
Total share-based compensation expense
Share-Based Payment Arrangement, Expense
Schedule of Property and Equipment
Property, Plant and Equipment [Table Text Block]
Common stock, shares authorized (in shares)
Common Stock, Shares Authorized
Net proceeds from issuances of common stock (in shares)
Stock issued (in shares)
Stock Issued During Period, Shares, New Issues
Forfeited (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period
Total liabilities, non-controlling interests and stockholders' equity
Liabilities and Equity
Foreign Currency Translation
Foreign Currency Transactions and Translations Policy [Policy Text Block]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]
Concentration of Risks
Concentration Risk, Credit Risk, Policy [Policy Text Block]
LIABILITIES, NON-CONTROLLING INTERESTS AND STOCKHOLDERS' EQUITY
Liabilities and Equity [Abstract]
State
State and Local Jurisdiction [Member]
Cover [Abstract]
Cover [Abstract]
Number of tradeable contingent value rights
Number of Tradeable Contingent Value Rights
Number of Tradeable Contingent Value Rights
Maximum
Maximum [Member]
General and administrative
General and Administrative Expense [Member]
Intangible asset, useful life
Finite-Lived Intangible Asset, Useful Life
Sublicensing fee
Collaborative Arrangement, Rights and Obligations, Sublicensing Fees
Collaborative Arrangement, Rights and Obligations, Sublicensing Fees
Investments in and Advances to Affiliates [Line Items]
Investments in and Advances to Affiliates [Line Items]
Accounting Policies [Abstract]
Accounting Policies [Abstract]
Shares canceled (in shares)
Investment Owned, Canceled, Shares
Investment Owned, Canceled, Shares
SAFE, discount rate
SAFE, Discount Rate
SAFE, Discount Rate
Restricted Stock
Restricted Stock [Member]
Non-PEO NEO Average Total Compensation Amount
Non-PEO NEO Average Total Compensation Amount
Payments to acquire Impilo SAFE
Payments to Acquire Other Investments
Vested or expected to vest (in dollars per share)
Weighted Average Exercise Price, Warrants Vested And Expected To Vest
Weighted Average Exercise Price, Warrants Vested And Expected To Vest
Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Treasury Stock
Treasury Stock, Common [Member]
Adjustment to Non-PEO NEO Compensation Footnote
Adjustment to Non-PEO NEO Compensation Footnote [Text Block]
Pay vs Performance Disclosure [Line Items]
Outstanding, weighted average remaining contractual term (in years)
Weighted Average Remaining Contractual Term warrant outstanding
Weighted Average Remaining Contractual Term warrant outstanding
Forgone Recovery due to Disqualification of Tax Benefits, Amount
Forgone Recovery due to Disqualification of Tax Benefits, Amount
Liabilities
Liabilities [Abstract]
Non-Rule 10b5-1 Arrangement Terminated
Non-Rule 10b5-1 Arrangement Terminated [Flag]
Annual license maintenance fee
Collaborative Arrangement, Rights and Obligations, Annual License Maintenance Fee
Collaborative Arrangement, Rights and Obligations, Annual License Maintenance Fee
Depreciation and amortization
Depreciation, Depletion and Amortization, Nonproduction
Entity Shell Company
Entity Shell Company
Schedule of Revenue by Major Customers, by Reporting Segments [Table]
Schedule of Revenue by Major Customers, by Reporting Segments [Table]
Other long-term liabilities
Other Liabilities, Noncurrent
Statement of Stockholders' Equity [Abstract]
Statement of Stockholders' Equity [Abstract]
Statement of Cash Flows [Abstract]
Statement of Cash Flows [Abstract]
Company Selected Measure Amount
Company Selected Measure Amount
Award Timing MNPI Considered
Award Timing MNPI Considered [Flag]
Comprehensive loss attributable to Lisata Therapeutics, Inc. common stockholders
Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Expired (in dollars per share)
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price
Name
Measure Name
Less than one year
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One
Schedule Share-Based Compensation Expense
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
Kuva
Kuva [Member]
Kuva
Document Fiscal Period Focus
Document Fiscal Period Focus
Other
Research And Development, Other [Member]
Research And Development, Other
Milestones and Royalties
Collaborative Arrangement, Accounting Policy [Policy Text Block]
Award Timing Method
Award Timing Method [Text Block]
Furniture and fixtures
Furniture and Fixtures [Member]
New Jersey
New Jersey Division of Taxation [Member]
Award Type [Axis]
Award Type [Axis]
Legal Entity [Axis]
Legal Entity [Axis]
Total assets
Assets
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Research and Development Costs
Research, Development, and Computer Software, Policy [Policy Text Block]
Investment, Name [Domain]
Investment, Name [Domain]
Share-Based Compensation
Share-Based Payment Arrangement [Policy Text Block]
Trading Symbol
Trading Symbol
Vested (in dollars per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value
Operating Loss Carryforwards [Table]
Operating Loss Carryforwards [Table]
Share-based compensation (in shares)
Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture
Entity Address, City or Town
Entity Address, City or Town
Cash flows from operating activities:
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]
Research tax credit rate
Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent
Technology Transfer Agreement [Abstract]
Technology Transfer Agreement
Effect of exchange rate changes on cash
Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation
Non-PEO NEO Average Compensation Actually Paid Amount
Non-PEO NEO Average Compensation Actually Paid Amount
Total share-based compensation expense
Statement of Income Location, Balance [Domain]
Restricted stock units
Restricted Stock Units (RSUs) [Member]
Potential milestone payments
Collaborative Arrangement, Rights and Obligations, Maximum Aggregate Milestone Payments, Per Product
Collaborative Arrangement, Rights and Obligations, Maximum Aggregate Milestone Payments, Per Product
Compensation Actually Paid vs. Other Measure
Compensation Actually Paid vs. Other Measure [Text Block]
Assets:
Assets, Fair Value Disclosure [Abstract]
Entity Emerging Growth Company
Entity Emerging Growth Company
Research and development
Research and Development Expense (Excluding Acquired in Process Cost)
Warrants
Warrant [Member]
Entity Common Stock, Shares Outstanding
Entity Common Stock, Shares Outstanding
Debt Securities, Available-for-sale [Line Items]
Debt Securities, Available-for-Sale [Line Items]
Outstanding, beginning balance (in shares)
Outstanding, ending balance (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number
Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year
Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]
Level 2
Fair Value, Inputs, Level 2 [Member]
Insider Trading Policies and Procedures Not Adopted
Insider Trading Policies and Procedures Not Adopted [Text Block]
Business Combination [Domain]
Business Combination [Domain]
Common stock outstanding (in shares)
Beginning balance (in shares)
Ending balance (in shares)
Common Stock, Shares, Outstanding
Allowance for credit losses
Accounts Receivable, Credit Loss Expense (Reversal)
Schedule of Classification of Available-for-Sale Securities
Marketable Securities [Table Text Block]
Property and Equipment
Property, Plant and Equipment, Policy [Policy Text Block]
PEO
PEO [Member]
Shares held by third party (in shares)
Shares Held by Third Party
Shares Held by Third Party
Schedule of Available-for-Sale Securities by Contractual Maturity
Investments Classified by Contractual Maturity Date [Table Text Block]
Income tax incentive receivable
Income Tax Incentive Receivable
Income Tax Incentive Receivable
Changes in operating assets and liabilities:
Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]
Proceeds from option exercises
Stock Issued During Period, Value, Stock Options Exercised
Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year
Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]
Intangible Assets
Intangible Assets, Finite-Lived, Policy [Policy Text Block]
Accumulated Deficit
Retained Earnings [Member]
Prepaid and other current assets
Prepaid Expense and Other Assets, Current
Income Tax Authority [Axis]
Income Tax Jurisdiction [Axis]
Shares
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Schedule of Accrued Liabilities
Schedule of Accrued Liabilities [Table Text Block]
Entity Address, Postal Zip Code
Entity Address, Postal Zip Code
Restatement Determination Date
Restatement Determination Date
Share-based Payment Arrangement [Abstract]
Share-Based Payment Arrangement [Abstract]
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation
Income Statement [Abstract]
Income Statement [Abstract]
Benefit from income taxes
Income Tax Expense (Benefit)
Revenue, Major Customer [Line Items]
Revenue, Major Customer [Line Items]
ASCEND trial
Ascend Trial [Member]
Ascend Trial
Sale of Stock, Name of Transaction [Domain]
Sale of Stock [Domain]
Preferred stock, shares issued (in shares)
Preferred Stock, Shares Issued
Intangible assets, net
Intangible Assets, Net (Excluding Goodwill)
Pension Adjustments Service Cost
Pension Adjustments Service Cost [Member]
Product and Service [Domain]
Product and Service [Domain]
Fair Value Hierarchy and NAV [Axis]
Fair Value Hierarchy and NAV [Axis]
Debt Securities, Available-for-sale [Abstract]
Debt Securities, Available-for-Sale [Abstract]
Outstanding, beginning balance (in dollars per share)
Outstanding, ending balance (in dollars per share)
Weighted Average Exercise Price, Warrants Outstanding
Weighted Average Exercise Price, Warrants Outstanding
Vested (in dollars per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price
Computer equipment
Property, Plant and Equipment, Gross
Total Lisata Therapeutics, Inc. Stockholders' Equity
Parent [Member]
Net loss
Net loss
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
Restatement does not require Recovery
Restatement Does Not Require Recovery [Text Block]
Business Combination [Table]
Business Combination [Table]
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Treasury Stock
Stockholders' Equity, Policy [Policy Text Block]
Compensation Actually Paid vs. Company Selected Measure
Compensation Actually Paid vs. Company Selected Measure [Text Block]
Proceeds from exercise of options
Proceeds from Stock Options Exercised
City Area Code
City Area Code
Award Timing, How MNPI Considered
Award Timing, How MNPI Considered [Text Block]
All Trading Arrangements
All Trading Arrangements [Member]
Equity Awards Adjustments, Footnote
Equity Awards Adjustments, Footnote [Text Block]
Total Shareholder Return Vs Peer Group
Total Shareholder Return Vs Peer Group [Text Block]
Vested or expected to vest, weighted average remaining contractual term (in years)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term
Accrued liabilities
Total
Accrued Liabilities, Current
Expired (in shares)
Warrants Expired, Shares
Warrants Expired, Shares
Beginning balance (in shares)
Ending balance (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Abstract]
Cash flows from investing activities:
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract]
General and administrative
General and Administrative Expense
Pay vs Performance Disclosure
Pay vs Performance Disclosure [Table]
Net cash used in operating activities
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Vested or expected to vest (in shares)
Vested and Expected to Vest, Shares
Vested and Expected to Vest, Shares
Useful life (in years)
Property, Plant and Equipment, Useful Life
Vested or expected to vest, weighted average remaining contractual term (in years)
Weighted Average Remaining Contractual Term, Warrants Vested and Expect to Vest
Weighted Average Remaining Contractual Term, Warrants Vested and Expect to Vest
Subsequent event
Subsequent Event [Member]
Equity Valuation Assumption Difference, Footnote
Equity Valuation Assumption Difference, Footnote [Text Block]
Clinical department
Clinical Department [Member]
Clinical Department
PEO Total Compensation Amount
PEO Total Compensation Amount
Depreciation
Depreciation
Vested and expected to vest (in dollars per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price
Money market funds
Money Market Funds [Member]
Statement, Equity Components [Axis]
Equity Components [Axis]
Exclusive License and Collaboration Agreement
Exclusive License and Collaboration Agreement [Member]
Exclusive License and Collaboration Agreement
New York
New York State Division of Taxation and Finance [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment [Line Items]
Value of shares issued
Stock Issued During Period, Value, Restricted Stock Award, Gross
Non-Rule 10b5-1 Arrangement Adopted
Non-Rule 10b5-1 Arrangement Adopted [Flag]
Number of reportable segments
Number of Reportable Segments
Operating loss carryforwards, post acquisition
Operating Loss Carryforwards, Post Acquisition
Operating Loss Carryforwards, Post Acquisition
Expired (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period
Cost
Debt Securities, Available-for-Sale, Amortized Cost
Other Performance Measure, Amount
Other Performance Measure, Amount
Weighted Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Entity Address, State or Province
Entity Address, State or Province
Outstanding, aggregate intrinsic value
Aggregate Intrinsic Value, Warrants Outstanding
Aggregate Intrinsic Value, Warrants Outstanding
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]
Antidilutive Security, Excluded EPS Calculation [Table]
Total current liabilities
Liabilities, Current
Income tax refunds
Proceeds from Income Tax Refunds
Number of shares issued (in shares)
Stock Issued During Period, Shares, Restricted Stock Award, Gross
Individual:
Individual [Axis]
Income Tax Holiday [Line Items]
Income Tax Holiday [Line Items]
Income Tax Authority [Domain]
Income Tax Jurisdiction [Domain]
Research and development
Research and Development Expense [Member]
Entity [Domain]
Entity [Domain]
Net cash provided by investing activities
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
Remaining unamortized expenses
Remaining Unamortized Research or Experimental Expenditures Expected To Be Deducted
Remaining Unamortized Research or Experimental Expenditures Expected To Be Deducted
Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table
Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]
ATM Agreement
At The Market Offering Agreement [Member]
At The Market Offering Agreement
Document Fiscal Year Focus
Document Fiscal Year Focus
Basis of Presentation
Basis of Accounting, Policy [Policy Text Block]
Forgone Recovery, Explanation of Impracticability
Forgone Recovery, Explanation of Impracticability [Text Block]
Effective income tax rate reconciliation
Effective Income Tax Rate Reconciliation, Percent
Entity Interactive Data Current
Entity Interactive Data Current
Software
Computer Software, Intangible Asset [Member]
Outstanding, beginning balance (in shares)
Outstanding, ending balance (in shares)
Common Stock Warrants, Shares
Common Stock Warrants, Shares
Expected weighted-average period in years of compensation cost to be recognized
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition
Proceeds from option exercises (in shares)
Exercised (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period
Equity [Abstract]
Equity [Abstract]
Revenue Recognition
Revenue from Contract with Customer [Policy Text Block]
Segment Information
Segment Reporting Disclosure [Text Block]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Disaggregation of Revenue [Table]
Disaggregation of Revenue [Table]
Pre-determined development milestone method, revenue potential
Pre-Determined Development Milestone Method, Revenue Potential
Pre-Determined Development Milestone Method, Revenue Potential
Long-Lived Tangible Asset [Axis]
Long-Lived Tangible Asset [Axis]
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vested, aggregate intrinsic value
Aggregate Intrinsic Value, Warrants Vested
Aggregate Intrinsic Value, Warrants Vested
Compensation Actually Paid vs. Total Shareholder Return
Compensation Actually Paid vs. Total Shareholder Return [Text Block]
Contingent liability
Business Combination, Contingent Consideration, Liability
Forfeited (in shares)
Warrants Canceled, Shares
Warrants Canceled, Shares
Fair Value, Recurring and Nonrecurring [Table]
Fair Value, Recurring and Nonrecurring [Table]
Amortization of intangible assets
Amortization of Intangible Assets
Basic and diluted loss per share
EPS [Abstract]
EPS
Other assets
Other Assets, Noncurrent
Entity Central Index Key
Entity Central Index Key
PEO Name
PEO Name
Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year
Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]
Weighted Average Remaining Contractual Term (Years) / Aggregate Intrinsic Value (In Thousands)
Warrants Other Disclosures [Abstract]
Warrants Other Disclosures
Outstanding Aggregate Erroneous Compensation Amount
Outstanding Aggregate Erroneous Compensation Amount
Accounts Receivable
Accounts Receivable [Policy Text Block]
Arrangement Duration
Trading Arrangement Duration
Limitation on NOL carryforwards
Limitation on Net Operating Loss Carryforwards
Limitation on Net Operating Loss Carryforwards
Computer equipment
Computer Equipment [Member]
Segments [Axis]
Segments [Axis]
Prepaid and other current assets
Increase (Decrease) in Prepaid Expense and Other Assets
Exercise Price
Award Exercise Price
Entity Filer Category
Entity Filer Category
Class of Stock [Domain]
Class of Stock [Domain]
Local Phone Number
Local Phone Number
Additional 402(v) Disclosure
Additional 402(v) Disclosure [Text Block]
Collaborative Arrangement and Arrangement Other than Collaborative [Domain]
Collaborative Arrangement and Arrangement Other than Collaborative [Domain]
Subsequent Event Type [Axis]
Subsequent Event Type [Axis]
Share-Based Compensation
Share-Based Payment Arrangement [Text Block]
ASSETS
Assets [Abstract]
Underlying Security Market Price Change
Underlying Security Market Price Change, Percent
Statement of Financial Position Location, Balance [Axis]
Statement of Financial Position Location, Balance [Axis]
Technology Transfer Agreement
Technology Transfer Agreement [Text Block]
Technology Transfer Agreement
Forfeited (in dollars per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value
Fair Value Measurements
Fair Value Disclosures [Text Block]
Cash and marketable securities
Cash, Cash Equivalents, and Marketable Securities
Cash, Cash Equivalents, and Marketable Securities
Business Combination [Line Items]
Business Combination [Line Items]
Stockholders' Equity
Equity, Attributable to Parent [Abstract]
Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year
Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]
Entity Address, Address Line One
Entity Address, Address Line One
Accumulated Other Comprehensive Loss
AOCI Attributable to Parent [Member]
Investment, Name [Axis]
Investment, Name [Axis]
Proceeds from warrant exercise (in shares)
Stock Issued During Period, Shares, Conversion of Convertible Securities
Finance
Finance, General And Administrative Expense
Finance, General And Administrative Expense
Fair Value as of Grant Date
Award Grant Date Fair Value
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment [Abstract]
Entity Registrant Name
Entity Registrant Name
Proceeds from exercise of warrants
Proceeds from Warrant Exercises
Stock Price or TSR Estimation Method
Stock Price or TSR Estimation Method [Text Block]
Shares issued under license agreement (in shares)
Shares Issued Under License Agreement
Shares Issued Under License Agreement
Net operating loss carryforwards
Operating Loss Carryforwards
Sale of stock available for sale
Sale of Stock Available for Sale
Sale of Stock Available for Sale
Granted (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period
Unrecognized compensation cost
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount
Forfeited (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period
Vested (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number
Document Quarterly Report
Document Quarterly Report
Assets, fair value
Assets, Fair Value Disclosure
Changed Peer Group, Footnote
Changed Peer Group, Footnote [Text Block]
Annual license maintenance fee, year seven
Collaborative Arrangement, Rights and Obligations, Annual License Maintenance Fee Starting at Year Seven
Collaborative Arrangement, Rights and Obligations, Annual License Maintenance Fee Starting at Year Seven
Counterparty Name [Domain]
Counterparty Name [Domain]
Number of operating segments
Number of Operating Segments
SAFE, valuation cap
SAFE, Valuation Cap
SAFE, Valuation Cap
Loss on sale of NOL
Loss On Sale of NOL
Loss On Sale of NOL
Proceeds from sale of NOLs, gross
Proceeds From Sale Of Net Operating Losses, NJEDA Program, Gross
Proceeds From Sale Of Net Operating Losses, NJEDA Program, Gross
Amortization/accretion on marketable securities
Accretion (Amortization) of Discounts and Premiums, Investments
Adjustment To PEO Compensation, Footnote
Adjustment To PEO Compensation, Footnote [Text Block]
Outstanding, weighted average remaining contractual term (in years)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term
Weighted average estimated fair value (in dollars per share)
Granted (in dollars per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value
Title
Trading Arrangement, Individual Title
Peer Group Total Shareholder Return Amount
Peer Group Total Shareholder Return Amount
Exercised (in dollars per share)
Weighted Average Exercise Price, Warrants Exercised
Weighted Average Exercise Price, Warrants Exercised
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Restatement Determination Date:
Restatement Determination Date [Axis]
Non-PEO NEO
Non-PEO NEO [Member]
Outstanding, aggregate intrinsic value
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value
Schedule of Fair Value of Shares Vested and Weighted Average Estimated Fair Values of Shares Granted
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value [Table Text Block]
Australian Taxation Office
Australian Taxation Office [Member]
Sale of Stock [Axis]
Sale of Stock [Axis]
Gross Unrealized Gains
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax
Name
Trading Arrangement, Individual Name
Award Type [Domain]
Award Type [Domain]
Non-controlling interests
Equity, Attributable to Noncontrolling Interest
Equity Awards Adjustments
Equity Awards Adjustments [Member]
Pension Benefits Adjustments, Footnote
Pension Benefits Adjustments, Footnote [Text Block]
Disaggregation of Revenue [Line Items]
Disaggregation of Revenue [Line Items]
Compensation Amount
Outstanding Recovery Compensation Amount
Business development
Business Development
Chemistry, manufacturing and controls
Chemistry Manufacturing And Controls [Member]
Chemistry Manufacturing And Controls
Impilo
Impilo [Member]
Impilo
Statement of Comprehensive Income [Abstract]
Statement of Comprehensive Income [Abstract]
Recovery of Erroneously Awarded Compensation Disclosure [Line Items]
MNPI Disclosure Timed for Compensation Value
MNPI Disclosure Timed for Compensation Value [Flag]
Greater than one year
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five
Name
Awards Close in Time to MNPI Disclosures, Individual Name
Beginning balance (in dollars per share)
Ending balance (in dollars per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
Royalties, net of sales
Collaborative Arrangement, Rights and Obligations, Royalties Net of Sales
Collaborative Arrangement, Rights and Obligations, Royalties Net of Sales
Aggregate Erroneous Compensation Not Yet Determined
Aggregate Erroneous Compensation Not Yet Determined [Text Block]
Proceeds from warrant exercise
Stock Issued During Period, Value, Conversion of Convertible Securities
Share-based compensation
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
Vested (in shares)
Warrants, Vested
Warrants, Vested
Accumulated other comprehensive loss
Accumulated Other Comprehensive Income (Loss), Net of Tax
Vested or expected to vest, aggregate intrinsic value
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value
Financial Instruments [Domain]
Financial Instruments [Domain]
Unrealized loss on marketable securities
OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax
Foreign Tax Authority
Foreign Tax Jurisdiction [Member]
Segment [Domain]
Segments [Domain]
Income Statement Location [Axis]
Statement of Income Location, Balance [Axis]
Available-for-Sale-Securities
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]
Aggregate Pension Adjustments Service Cost
Aggregate Pension Adjustments Service Cost [Member]
Royalty
Royalty [Member]
Fair Value Hierarchy and NAV [Domain]
Fair Value Hierarchy and NAV [Domain]
Statement of Financial Position Location, Balance [Domain]
Statement of Financial Position Location, Balance [Domain]
Finite-Lived Intangible Assets by Major Class [Axis]
Finite-Lived Intangible Assets by Major Class [Axis]
Minimum
Minimum [Member]
Income Tax Authority, Name [Domain]
Income Tax Authority, Name [Domain]
Vested, weighted average remaining contractual term (in years)
weighted Average Remaining Contractual Term, warrants vested
weighted Average Remaining Contractual Term, warrants vested
Accumulated depreciation
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment
Loss Per Share
Earnings Per Share, Policy [Policy Text Block]
Company Selected Measure Name
Company Selected Measure Name
Aggregate Available
Trading Arrangement, Securities Aggregate Available Amount
Accounts payable
Accounts Payable, Current
Stock Appreciation Rights (SARs)
Stock Appreciation Rights (SARs) [Member]
All Executive Categories
All Executive Categories [Member]
Impairment of non-financial asset
Impairment of Intangible Assets (Excluding Goodwill)
Common stock, $0.001 par value, authorized 500,000,000 shares; issued 9,108,029 and 8,834,613 shares at March 31, 2026 and December 31, 2025, respectively; and outstanding, 9,107,291 and 8,833,875 shares at March 31, 2026 and December 31, 2025, respectively
Common Stock, Value, Issued
Contingencies
Commitments and Contingencies Disclosure [Text Block]
Diluted shares (in shares)
Weighted Average Number of Shares Outstanding, Diluted
Segment Information
Segment Reporting, Policy [Policy Text Block]
Contingencies (Note 13)
Commitments and Contingencies
Total fair value of shares vested
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value
Non-GAAP Measure Description
Non-GAAP Measure Description [Text Block]
Business Combination [Axis]
Business Combination [Axis]
Entity Small Business
Entity Small Business
Income Tax Disclosure [Abstract]
Income Tax Disclosure [Abstract]
Non- Controlling Interest in Subsidiary
Noncontrolling Interest [Member]
Document Transition Report
Document Transition Report
CEND
CEND [Member]
CEND
Greater than one year
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five
Ownership percentage
Equity Method Investment, Ownership Percentage
Underlying Securities
Award Underlying Securities Amount
Equity Component [Domain]
Equity Component [Domain]
Document Period End Date
Document Period End Date
PEO Actually Paid Compensation Amount
PEO Actually Paid Compensation Amount
Reportable Segment
Reportable Segment [Member]
Reportable Segment
Income Taxes
Income Tax Disclosure [Text Block]
Awards Close in Time to MNPI Disclosures, Table
Awards Close in Time to MNPI Disclosures [Table Text Block]
Expired (in dollars per share)
Weighted Average Exercise Price, Warrants Expired
Weighted Average Exercise Price, Warrants Expired
Schedule of Investments [Table]
Schedule of Investments [Table]
Total equity
Beginning balance
Ending balance
Equity, Including Portion Attributable to Noncontrolling Interest
Vested or expected to vest, aggregate intrinsic value
Aggregate Intrinsic Value, Warrants Vested And Expected To Vest
Aggregate Intrinsic Value, Warrants Vested And Expected To Vest
Document Type
Document Type
Level 3
Fair Value, Inputs, Level 3 [Member]
Income (Loss) Per Share
Earnings Per Share [Text Block]
Name
Outstanding Recovery, Individual Name
Percentage of sublicensing revenues
Revenue, Performance Obligation, Percentage of Sublicensing Revenues
Revenue, Performance Obligation, Percentage of Sublicensing Revenues
Additional paid-in capital
Additional Paid in Capital
Product and Service [Axis]
Product and Service [Axis]
Net proceeds from issuance of common stock
Proceeds from Issuance of Common Stock
Revenue
Revenue from Contract with Customer, Excluding Assessed Tax
Percentage of net sale
Revenue, Performance Obligation, Percentage of Net Sale
Revenue, Performance Obligation, Percentage of Net Sale
Collaborative Arrangement, Transaction with Party to Collaborative Arrangement
Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member]
All Individuals
All Individuals [Member]
Legal liabilities
Legal Liabilities, Current
Legal Liabilities, Current
Fair Value Disclosures [Abstract]
Fair Value Disclosures [Abstract]
Purchase of property and equipment
Payments to Acquire Property, Plant, and Equipment
Vested and expected to vest (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number
Name
Forgone Recovery, Individual Name
Total current assets
Assets, Current
Statistical Measurement [Axis]
Statistical Measurement [Axis]
Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested
Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]
Exercised (in shares)
Warrants Exercised, Shares
Warrants Exercised, Shares
Aggregate Erroneous Compensation Amount
Aggregate Erroneous Compensation Amount
Tax withholding payments on net share settlement equity awards
Payment, Tax Withholding, Share-Based Payment Arrangement
Peer Group Issuers, Footnote
Peer Group Issuers, Footnote [Text Block]
Erroneous Compensation Analysis
Erroneous Compensation Analysis [Text Block]
Weighted Average Remaining Contractual Term (Years) / Aggregate Intrinsic Value (In Thousands)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]
Total operating expenses
Operating Expenses
Rule 10b5-1 Arrangement Terminated
Rule 10b5-1 Arrangement Terminated [Flag]
Price per share of the common stock acquired
Business Combination, Price Per Share
Variable consideration amounts, milestones
Revenue, Remaining Performance Obligation, Variable Consideration Amount
Revenue, Remaining Performance Obligation, Variable Consideration Amount
Fair value market of tax NOLs
Fair Value Market of Tax NOLs
Fair Value Market of Tax NOLs
Level 1
Fair Value, Inputs, Level 1 [Member]
Clinical and R&D related liabilities
Clinical and Research And Development Related Liabilities, Current
Clinical and Research And Development Related Liabilities, Current
Lisata Therapeutics, Inc. common stockholders - diluted (in dollars per share)
Earnings Per Share, Diluted
Erroneously Awarded Compensation Recovery
Erroneously Awarded Compensation Recovery [Table]
Aggregate offering amount authorized per agreement
Sale Of Stock, Aggregate Offering Amount Authorized Per Agreement
Sale Of Stock, Aggregate Offering Amount Authorized Per Agreement
Title of 12(b) Security
Title of 12(b) Security
Vested, aggregate intrinsic value
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value
Accounts payable, accrued liabilities and other liabilities
Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities
Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities
Treasury stock (in shares)
Treasury Stock, Common, Shares
Earnings Per Share [Abstract]
Earnings Per Share [Abstract]
Outstanding stock threshold
Outstanding Stock Threshold
Outstanding Stock Threshold
Consolidation Items [Domain]
Consolidation Items [Domain]
Description of Business
Business Description and Basis of Presentation [Text Block]
Total other income
Nonoperating Income (Expense)
Weighted Average Exercise Price
Warrants Weighted Average Exercise Price [Roll Forward]
Warrants Weighted Average Exercise Price [Roll Forward]
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
Tax credit carryforward
Tax Credit Carryforward, Amount
Federal
Domestic Tax Jurisdiction [Member]
Accrued Liabilities
Accounts Payable and Accrued Liabilities Disclosure [Text Block]
Tax Credit Carryforward [Axis]
Tax Credit Carryforward [Axis]
California
California Franchise Tax Board [Member]
Exercised (in dollars per share)
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
Cash equivalents
Cash Equivalents [Member]
Schedule of Restricted Stock
Nonvested Restricted Stock Shares Activity [Table Text Block]
Collaborative Arrangement and Arrangement Other than Collaborative [Table]
Collaborative Arrangement and Arrangement Other than Collaborative [Table]
Award Timing Disclosures [Line Items]
Operating Loss Carryforwards [Line Items]
Operating Loss Carryforwards [Line Items]
Granted (in dollars per share)
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Salaries, employee benefits and related taxes
Employee-related Liabilities, Current
Property and Equipment
Property, Plant and Equipment Disclosure [Text Block]
Available for sale securities - net unrealized loss
OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax
Stockholders' Equity
Equity [Text Block]
Investment owned (in shares)
Investment Owned, Balance, Shares
Net loss attributable to Lisata Therapeutics, Inc. common stockholders
Net Income (Loss) Attributable to Parent
Expiration Date
Trading Arrangement Expiration Date
Other
Other Accrued Liabilities, Current
Vesting term
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period
Forfeited (in dollars per share)
Weighted Average Exercise Price, Warrants Canceled
Weighted Average Exercise Price, Warrants Canceled
Property and equipment, net
Property and equipment, net
Property, Plant and Equipment, Net
Granted (in dollars per share)
Weighted Average Exercise Price, Warrants Granted
Weighted Average Exercise Price, Warrants Granted
Sanford Burnham Prebys
Sanford Burnham Prebys [Member]
Sanford Burnham Prebys
Adoption Date
Trading Arrangement Adoption Date
Lisata
Lisata [Member]
Lisata
Vested, weighted average remaining contractual term (in years)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term
Compensation Actually Paid vs. Net Income
Compensation Actually Paid vs. Net Income [Text Block]
Accounts receivable
Increase (Decrease) in Accounts Receivable
Entity Current Reporting Status
Entity Current Reporting Status
Awards Close in Time to MNPI Disclosures
Awards Close in Time to MNPI Disclosures [Table]
Operating loss
Operating Income (Loss)
Less than one year
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One
Accumulated deficit
Retained Earnings (Accumulated Deficit)
Financial Instrument [Axis]
Financial Instrument [Axis]
Statement of Financial Position [Abstract]
Statement of Financial Position [Abstract]
Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested
Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]
Executive Category:
Executive Category [Axis]
Class of Stock [Axis]
Class of Stock [Axis]
Current Fiscal Year End Date
Current Fiscal Year End Date
Subsequent Event Type [Domain]
Subsequent Event Type [Domain]
Finite-Lived Intangible Assets, Major Class Name [Domain]
Finite-Lived Intangible Assets, Major Class Name [Domain]
Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table
Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]
Weighted Average Grant-Date Fair Value
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Statement [Table]
Statement [Table]
Other expense, net
Other income, net
Other Nonoperating Income (Expense)
Adjustments to reconcile net loss to net cash used in operating activities:
Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract]
License Agreements
Research Collaboration and License Agreements
Collaborative Arrangement Disclosure [Text Block]
Cash flows from financing activities:
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]
Weighted average estimated fair value of shares granted
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
Equity Awards Adjustments, Excluding Value Reported in Compensation Table
Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]
Less - net income (loss) attributable to noncontrolling interests
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest
Legal
Legal, General And Administrative Expense
Legal, General And Administrative Expense
Contract with customer, liability
Contract with Customer, Liability
Amortized Cost
Debt Securities, Available-for-Sale, Amortized Cost, Fiscal Year Maturity [Abstract]
Sale of marketable securities
Proceeds from Sale and Maturity of Marketable Securities
Granted (in shares)
Warrants Granted, Shares
Warrants Granted, Shares
Unrecognized tax benefits
Unrecognized Tax Benefits
Antidilutive securities excluded from computation of earnings per share (in shares)
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Weighted average common shares outstanding
Weighted Average Number of Shares Outstanding, Diluted [Abstract]
All Adjustments to Compensation
All Adjustments to Compensation [Member]
Amendment Flag
Amendment Flag
Estimated Fair Value
Debt Securities, Available-for-Sale, Fair Value, Fiscal Year Maturity [Abstract]
Treasury stock, at cost; 738 shares at March 31, 2026 and December 31, 2025
Treasury Stock, Common, Value
Termination Date
Trading Arrangement Termination Date
Net cash provided by (used in) financing activities
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Insider Trading Policies and Procedures Adopted
Insider Trading Policies and Procedures Adopted [Flag]
Accrued Liabilities [Abstract]
Accrued Liabilities [Abstract]
Measure:
Measure [Axis]
Schedule of Stock Option and Warrants Activity
Share-Based Payment Arrangement, Option, Activity [Table Text Block]
Long-Lived Tangible Asset [Domain]
Long-Lived Tangible Asset [Domain]
Schedule of Assets Measured at Fair Value on Recurring Basis
Fair Value, Assets Measured on Recurring Basis [Table Text Block]
Basic shares (in shares)
Weighted Average Number of Shares Outstanding, Basic
Segment Reporting [Abstract]
Segment Reporting [Abstract]
Proceeds from sale of NOLs
Proceeds From Sale of NOLS
Proceeds From Sale of NOLS
Australia Research and Development Tax Incentive
Research and Development Tax Incentive [Text Block]
Research and Development Tax Incentive
Pay vs Performance Disclosure, Table
Pay vs Performance [Table Text Block]
Forgone Recovery due to Violation of Home Country Law, Amount
Forgone Recovery due to Violation of Home Country Law, Amount
Other income (expense):
Nonoperating Income (Expense) [Abstract]
Entity Tax Identification Number
Entity Tax Identification Number
Income Tax Authority, Name [Axis]
Income Tax Authority, Name [Axis]
Outstanding, beginning balance (in dollars per share)
Outstanding, ending balance (in dollars per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Forgone Recovery due to Expense of Enforcement, Amount
Forgone Recovery due to Expense of Enforcement, Amount
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Common stock, par value (in dollars per share)
Common Stock, Par or Stated Value Per Share
Common stock, shares issued (in shares)
Common Stock, Shares, Issued
Granted (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross
Use of Estimates
Use of Estimates, Policy [Policy Text Block]
Trading Arrangement:
Trading Arrangement [Axis]
Total Shareholder Return Amount
Total Shareholder Return Amount
Cumulative translation adjustment arising during the period
Foreign currency translation adjustment
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax
Insider Trading Arrangements [Line Items]
Corporate
Segment Reporting, Reconciling Item, Corporate Nonsegment [Member]
Security Exchange Name
Security Exchange Name
Forfeited (in dollars per share)
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]
Termination of contract, lapse of payment
Termination of Contract, Lapse of Payment
Termination of Contract, Lapse of Payment
Total liabilities
Liabilities
Antidilutive Securities, Name [Domain]
Antidilutive Securities, Name [Domain]
In-process Research and Development Expense
In Process Research and Development, Policy [Policy Text Block]
Investment income, net
Investment Income, Net
Qilu
Qilu [Member]
Qilu
Common stock, value, outstanding
Common Stock, Value, Outstanding
Pension Adjustments Prior Service Cost
Pension Adjustments Prior Service Cost [Member]
Operating Expenses:
Operating Expenses [Abstract]
Material Terms of Trading Arrangement
Material Terms of Trading Arrangement [Text Block]
Contingent Value Rights (CVRs)
Contingent Value Rights (CVRs) [Member]
Contingent Value Rights (CVRs)
Net proceeds from issuances of common stock
Stock Issued During Period, Value, New Issues
Statement [Line Items]
Statement [Line Items]
Consolidation Items [Axis]
Consolidation Items [Axis]
Rule 10b5-1 Arrangement Adopted
Rule 10b5-1 Arrangement Adopted [Flag]
Cash and cash equivalents
Cash and Cash Equivalent
Counterparty Name [Axis]
Counterparty Name [Axis]
Schedule of Restricted Stock Units
Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]
Research Tax Credit Carryforward
Research Tax Credit Carryforward [Member]
Common Stock
Common Stock [Member]
Vested (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period
Estimated Fair Value
Total
Total
Cash equivalents and Marketable securities - available for sale
Debt Securities, Available-for-Sale
Tax Credit Carryforward, Name [Domain]
Tax Credit Carryforward, Name [Domain]
Entity Incorporation, State or Country Code
Entity Incorporation, State or Country Code
Non-NEOs
Non-NEOs [Member]
Net (decrease) increase in cash and cash equivalents
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation
Accounting & tax consulting liabilities
Accrued Professional Fees, Current